Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (961-970 of 1,482) with videos related to

Pageof 149
Sort By:
Blood|September 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AMLReeja Raj, Samanta Catueno, Amber Gibson, et al.
British Journal of Haematology|August 23, 2023
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemiaGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Ziyi Li, et al.
American Journal of Hematology|November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomesKoji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Cancer|June 28, 2021
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapySangeetha Venugopal, Mahran Shoukier, Marina Konopleva, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Open Forum Infectious Diseases|August 13, 2025
Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic CultureClement Gascua Adu Gyamfi, Abigail Seeger, Durbbin Mulengwa, et al.
NEJM Evidence|May 28, 2024
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure SyndromesTapan M Kadia, Meixian Huang, Naveen Pemmaraju, et al.
The Oncologist|November 18, 2018
Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer CareGeorge Simon, Courtney D DiNardo, Koichi Takahashi, et al.
Blood|November 19, 2024
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AMLWarren Fiskus, Christopher P Mill, Prithviraj Bose, et al.
The Lancet. Oncology|January 21, 2018
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 studyHagop Kantarjian, Farhad Ravandi, Nicholas J Short, et al.
Pageof 149

Showing results (961-970 of 1,482) with videos related to

Sort By:
Pageof 149
Blood|September 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AMLReeja Raj, Samanta Catueno, Amber Gibson, et al.
British Journal of Haematology|August 23, 2023
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemiaGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Ziyi Li, et al.
American Journal of Hematology|November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomesKoji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Cancer|June 28, 2021
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapySangeetha Venugopal, Mahran Shoukier, Marina Konopleva, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Open Forum Infectious Diseases|August 13, 2025
Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic CultureClement Gascua Adu Gyamfi, Abigail Seeger, Durbbin Mulengwa, et al.
NEJM Evidence|May 28, 2024
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure SyndromesTapan M Kadia, Meixian Huang, Naveen Pemmaraju, et al.
The Oncologist|November 18, 2018
Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer CareGeorge Simon, Courtney D DiNardo, Koichi Takahashi, et al.
Blood|November 19, 2024
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AMLWarren Fiskus, Christopher P Mill, Prithviraj Bose, et al.
The Lancet. Oncology|January 21, 2018
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 studyHagop Kantarjian, Farhad Ravandi, Nicholas J Short, et al.
Pageof 149